Early Induction and Maintenance of Env-Specific T-Helper Cells following Human Immunodeficiency Virus Type 1 Infection
Open Access
- 15 February 2003
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 77 (4) , 2663-2674
- https://doi.org/10.1128/jvi.77.4.2663-2674.2003
Abstract
Mounting evidence points to a role for CD4+ T-helper (Th) cell activities in controlling human immunodeficiency virus type 1 (HIV-1) infection. To determine the induction and evolution of Th responses following acute infection, we prospectively analyzed Env- and Gag-specific Th responses longitudinally for 92 patients with acute (n = 28) or early (n = 64) HIV-1 infection (median, 55 days postinfection [DPI]). The probability of detecting HIV-1-specific lymphoproliferative responses was remarkably low, and when present, the responses were more likely to be Gag specific than Env specific (16 versus 5%). Env-specific responses were significantly more common in patients presenting at P = 0.001). By contrast, Gag-specific responses occurred with similar frequencies among subjects presenting at P = 0.6). After treatment, and regardless of the duration of infection before therapy, Gag-specific Th responses predominated. Furthermore, some acutely infected subjects lost detectable Env-specific Th proliferative responses, which failed to reemerge upon treatment. Detailed analysis for one such subject revealed Env-specific lymphoproliferation at 11 DPI but no detectable Env-specific lymphoproliferation or ex vivo gamma interferon (IFN-γ) secretion at multiple subsequent time points. Env-specific CD4+ T-cell clones from 11 DPI recognized six epitopes in both conserved and variable regions within gp120 and gp41, exhibited major histocompatibility complex-restricted cytotoxicity, and secreted high levels of antiviral cytokines. T-cell receptor clonal transcript analyses and autologous virus sequencing revealed that Th cells induced during acute infection were maintained and there were no Th escape mutations. Subsequent analysis for this subject and six of seven others revealed detectable IFN-γ-secreting cells, but only following in vitro gp160 stimulation. In summary, we conclude that Env-specific Th responses are elicited very early in acute infection and may precede Gag-specific responses. The inability to detect Env-specific Th responses over time and despite antiretroviral therapy may reflect low frequencies and impaired proliferative capacity, and viral escape is not necessary for this to occur.Keywords
This publication has 34 references indexed in Scilit:
- Role for HLA class II molecules in HIV-1 suppression and cellular immunity following antiretroviral treatmentJournal of Clinical Investigation, 2001
- Risk Factors for Diphtheria: A Prospective Case‐Control Study in the Republic of Georgia, 1995–1996The Journal of Infectious Diseases, 2000
- Early and Persistent Human Immunodeficiency Virus Type 1 (HIV?1)–Specific T Helper Dysfunction in Blood and Lymph Nodes following Acute HIV?1 InfectionThe Journal of Infectious Diseases, 1999
- Recognition of a Small Number of Diverse Epitopes Dominates the Cytotoxic T Lymphocyte Response to HIV Type 1 in an Infected IndividualAIDS Research and Human Retroviruses, 1997
- A novel method for real time quantitative RT-PCR.Genome Research, 1996
- CD40L-deficient mice show deficits in antiviral immunity and have an impaired memory CD8+ CTL response.The Journal of Experimental Medicine, 1996
- CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choiceNucleic Acids Research, 1994
- Application OF Branched DNA Signal Amplification to Monitor Human Immunodeficiency Virus Type 1 Burden in Human PlasmaThe Journal of Infectious Diseases, 1994
- Simian Immunodeficiency Virus SIVsmmPBj 1.9 Induces Multinucleated Giant Cell Formation in Human Peripheral Blood MonocytesAIDS Research and Human Retroviruses, 1994
- Antigenic peptides recognized by T lymphocytes from AIDS viral envelope-immune humansNature, 1988